Physician profile
Vera Trofimenko
NPI 1518224112
$4,217.86
in general payments reported to CMS, 2019-2025
30 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,113 · 2020: $250 · 2021: $426 · 2022: $711 · 2023: $890 · 2024: $425 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,617.58 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,015.24 | 2019-2024 | |
| Teleflex LLC | $635.79 | 2021-2025 | Urolift, Solesta, Barrigel |
| Astellas Pharma US INC | $524.37 | 2019-2024 | Veozah, Myrbetriq |
| Medtronic, INC. | $324.48 | 2021-2024 | Interstim |
| Allergan, INC. | $292.76 | 2019-2022 | |
| Abbvie INC. | $216.76 | 2022-2025 | Botox |
| Axonics, INC. | $187.94 | 2022-2023 | Axonics |
| Bluewind Medical | $121.54 | 2024 | |
| Photocure INC | $113.26 | 2019-2025 | Cysview |
| Procept Biorobotics Corporation | $85.69 | 2022 | |
| Accord Healthcare, INC. | $71.80 | 2024-2025 | |
| Pfizer INC. | $57.37 | 2019-2025 | |
| 180 Medical, INC. | $55.27 | 2020-2022 | |
| Boston Scientific Corporation | $53.17 | 2019-2025 | Spaceoar System |
| Abc Home Medical Supply, INC. | $47.88 | 2022-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $46.04 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Neotract INC. | $43.98 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $41.66 | 2021-2024 | Prolaris |
| Urogen Pharma, INC. | $39.13 | 2025 | |
| Palette Life Sciences, INC. | $31.19 | 2022 | |
| Aytu Biopharma, INC. | $28.03 | 2019 | |
| Therapeuticsmd, INC. | $26.92 | 2019 | |
| Medtronic USA, INC. | $25.95 | 2020 | |
| Bioprotect Medical, INC. | $25.04 | 2025 | Bioprotect Balloon Implant System |
| Novartis Pharmaceuticals Corporation | $22.97 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.01 | 2021 | |
| Antares Pharma, INC. | $19.79 | 2025 | Xyosted |
| Urovant Sciences INC | $17.29 | 2022 | |
| Rochester Medical Corporation | $13.20 | 2021 | |
| Agiliti Surgical, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vera Trofimenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.